Useful resources |
Immunosuppressive agents for treating IgA nephropathy (Cochrane Review) ABSTRACT Background: IgA nephropathy (IgAN) is a world-wide disease and the cause of end-stage renal failure (ESRF) in 15 to 20% of patients within 10 years and in 30 to 40% of individuals within 20 years from the apparent onset of disease. No specific treatment has yet . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |